BiotechPurple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough100% left coverage1 source
BiotechPurple Biotech Shares Surge Over 90% After Tri-Specific Antibody Manufacturing Breakthrough100% left coverage1 source
BiotechPDS Biotech Seeks FDA Expedited Approval for HPV16-Positive Cancer Immunotherapy100% left coverage1 source
BiotechPDS Biotech Seeks FDA Expedited Approval for HPV16-Positive Cancer Immunotherapy100% left coverage1 source
BiotechTrinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet100% left coverage1 source
BiotechTrinity Biotech Reports Perceptive Advisors Plans Debt-to-Equity Conversion to Strengthen Balance Sheet100% left coverage1 source
BiotechNovartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies50% center coverage2 sources
BiotechNovartis Plans $12B Acquisition to Expand Neuroscience RNA Therapies50% center coverage2 sources
BiotechIO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma100% left coverage1 source
BiotechIO Biotech Reports Promising Phase 3 Results for Cylembio and Keytruda in Advanced Melanoma100% left coverage1 source